BridgeMD
New treatment option for Hemiparesis/Hemiplegia (One Sided Weakness/Paralysis)
Official title Isokinetic Strength Training in Hemiparetic Patient With Knee Extension Thrust
ClinicalTrials.gov ID: NCT05887440
What this study is testing
- What it's testing
- The purpose of this study is to assess the impact of an isokinetic strength training of knee flexor and extensor muscles on walking performance in hemiparetic patients with knee extension thrust.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75
You may be able to join if
- Hemiparetic patient (hemorragic or ischemic stroke)
- Subacute stage (\ 6 months) (6 patients in each group)
- Age between 18 and 75 years
- Able to walk 10 meters independently without any assistive devices
- Knee extension thrust during stance phase of gait cycle (rapid posterior movement of the knee toward extension)
You likely can't join if
- Major comprehension deficit that not allow to give informed consent and participate to isokinetic strength training (assessed with comprehension...
- non stable (unstable cardiovascular condition)
- musculoskeletal disorders with knee pain that not allowed isokinetic strength training
- Botulinum toxin injection less than 3 months or repeated injection in lower limb,
- Proprioception trouble assessed with proprioception section of the Fugl-Meyer Assessment [FMA-P] 0/2
- spasticity of triceps surae ≥2 (Modified Ashworth scale)
See the full eligibility criteria
- Hemiparetic patient (hemorragic or ischemic stroke)
- Subacute stage (\ 6 months) (6 patients in each group)
- Age between 18 and 75 years
- Able to walk 10 meters independently without any assistive devices
- Knee extension thrust during stance phase of gait cycle (rapid posterior movement of the knee toward extension)
- Scheduled rehabilitation program with isokinetic strength training
- affiliation to a social security
- Patients who received and signed informed consent
- Major comprehension deficit that not allow to give informed consent and participate to isokinetic strength training (assessed with comprehension subscore of Langague screening Test)
- non stable (unstable cardiovascular condition)
- musculoskeletal disorders with knee pain that not allowed isokinetic strength training
- Botulinum toxin injection less than 3 months or repeated injection in lower limb,
- Proprioception trouble assessed with proprioception section of the Fugl-Meyer Assessment [FMA-P] 0/2
- spasticity of triceps surae ≥2 (Modified Ashworth scale)
- ankle dorsiflexion angle less than 90°
- pregnant women or breastfeeding
- persons with safety measure
The study team makes the final eligibility decision.
Where it's taking place
- Rennes, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Rennes, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.